VeriMomVeriMom
HIGH RISK

Стоит ли избегать ci 77947 при беременности? | VeriMom

Zinc oxide (CI 77947, CAS 1314-13-2) has no harmonised reproductive classification (ECHA Annex VI lists only environmental classifications H400/H410). Authoritative cosmetic panels (e.g., SCCS/CIR) regard zinc oxide as safe for topical use in cosmetics/sunscreens under their conditions; systemic dermal absorption is minimal, so reproductive hazard and exposure during pregnancy are not indicated. Note: some non‑harmonised notifications (e.g., aggregated PubChem GHS entries) include H361, but these are self-notifications/aggregations and are not harmonised and thus do not override higher-priority sources.

ECHA regulatory hazard statements

  • H400
  • H410

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

Безопасен ли ci 77947 при беременности?
Zinc oxide (CI 77947, CAS 1314-13-2) has no harmonised reproductive classification (ECHA Annex VI lists only environmental classifications H400/H410). Authoritative cosmetic panels (e.g., SCCS/CIR) regard zinc oxide as safe for topical use in cosmetics/sunscreens under their conditions; systemic dermal absorption is minimal, so reproductive hazard and exposure during pregnancy are not indicated. Note: some non‑harmonised notifications (e.g., aggregated PubChem GHS entries) include H361, but these are self-notifications/aggregations and are not harmonised and thus do not override higher-priority sources.
Безопасен ли ci 77947 при грудном вскармливании?
Because dermal/systemic absorption of zinc oxide from topical formulations is negligible under normal use (per SCCS/CIR assessments), maternal systemic exposure that could transfer to breast milk is not expected. No authoritative evidence of reproductive/lactational toxicity from harmonised classifications.
Безопасен ли ci 77947 для кожи малыша?
Hazard and mechanism: no infant-specific reproductive/toxic mechanism identified. Exposure: while adult dermal absorption is negligible, zinc oxide is not absolutely non-absorbable and infants (0–3 yr) have an immature skin barrier/higher surface‑area‑to‑body‑weight, so exposure score is increased by +1 relative to adults. SCCS/CIR accept topical use (including in sunscreens and barrier creams) given minimal systemic uptake, but infant-specific absorption data are limited.
Как VeriMom оценивает ci 77947?
VeriMom оценивает ci 77947 в 39/100 (высокий риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.
Какие безопасные альтернативы ci 77947 при беременности?
См. наш список безопасных альтернатив ci 77947 с аналогичной функцией и классификацией без известных рисков.

Проверь любой состав за 2 секунды

Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.

Медицинская оговорка

Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.

Получите полный доступ в приложении VeriMom